Water → HCID 86703990, Verbindung

HRID 1773911Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1773911
I[C:2]1[N:11]=[C:10]2[N:4]([CH2:5][CH2:6][C:7]3[CH:23]=[CH:22][CH:21]=[CH:20][C:8]=3[CH:9]2[O:12][CH:13]2[CH2:18][CH2:17][N:16]([CH3:19])[CH2:15][CH2:14]2)[C:3]=1[CH3:24].C([O-])([O-])=O.[K+].[K+].[OH:31][C@H:32]1[CH2:37][CH2:36][C@H:35]([NH:38][C:39]([C:41]2[CH:46]=[CH:45][C:44](B(O)O)=[CH:43][CH:42]=2)=[O:40])[CH2:34][CH2:33]1.O>C1COCC1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[OH:31][CH:32]1[CH2:33][CH2:34][CH:35]([NH:38][C:39](=[O:40])[C:41]2[CH:46]=[CH:45][C:44]([C:2]3[N:11]=[C:10]4[N:4]([CH2:5][CH2:6][C:7]5[CH:23]=[CH:22][CH:21]=[CH:20][C:8]=5[CH:9]4[O:12][CH:13]4[CH2:18][CH2:17][N:16]([CH3:19])[CH2:15][CH2:14]4)[C:3]=3[CH3:24])=[CH:43][CH:42]=2)[CH2:36][CH2:37]1

Komponenten

7

Edukt 4

HCID 962WaterHCID 11430Potassium CarbonateHCID 86703973HCID 86703973, VerbindungHCID 178523805HCID 178523805, Verbindung

Produkt 1

HCID 86703990HCID 86703990, Verbindung

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 178418228Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+)KatalysatorHCID 8028TetrahydrofuranLösungsmittel

Reaktionsbedingungen

Temperatur
95 °C

Versuchsvorschrift

To a solution of 2-iodo-1-methyl-4-(1-methylpiperidin-4-yloxy)-9,10-dihydro-4H-3,10a-diaza-benzo[f]azulene (example 133) (50 mg, 0.114 mmoles) in THF (0.7 mL) in a screw-capped vial under argon are added a 1M aqueous solution of K2CO3 (0.5 mL, 0.5 mmole), PdCl2(dppf)2 (4.5 mg, 6 μmole) and 4-(trans-4-hydroxycyclohexylcarbamoyl)phenylboronic acid (45 mg, 0.150 mmole). The reaction mixture is heated at 95° C. overnight. Water is added to the reaction mixture and the aqueous phase is extracted three times with CH2Cl2. The organic phase is dried over magnesium sulphate, filtered and the solvent is removed under reduced pressure. The residue is pre-purified by silica gel chromatography using (CH2Cl2:MeOH:NH4OH) with a gradient from (98:2:0.2) to (96.5:3.5:0.35). The residue is purified by preparative TLC over silica gel using (CH2Cl2:MeOH:NH4OH) with a gradient from (9:1:1) to afford N-(4-hydroxycyclohexyl)-4-[1-methyl-4-(1-methylpiperidin-4-yloxy)-9,10-dihydro-4H-3,10a-diaza-benzo[f]azulen-2-yl]benzamide.

Aufarbeitung

  1. extractionthe aqueous phase is extracted three times with CH2Cl2
  2. dry with materialThe organic phase is dried over magnesium sulphate
  3. filtrationfiltered
  4. customthe solvent is removed under reduced pressure
  5. customThe residue is pre-purified by silica gel chromatography
  6. customThe residue is purified by preparative TLC over silica gel using (CH2Cl2:MeOH:NH4OH) with a gradient from (9:1:1)

Quellen und Nachweise

ORD-Eintrag
ord-850bf987aa6e4d31844cc2da1c5b9527
Quelldatensatz
uspto-grants-2016_02
Patentnummer
US09255101B2

Notizen zur Reaktion

Wird geladen…